---
title: Research
---

<style>
  .wrap { max-width: 980px; margin: 0 auto; padding: 0 14px; }

  .page-title { margin: 14px 0 6px; font-size: 2.0rem; }
  .lede { margin: 0 0 16px; font-size: 1.05rem; line-height: 1.7; opacity: .92; }

  .card {
    border: 1px solid rgba(0,0,0,.08);
    border-radius: 14px;
    padding: 18px;
    background: rgba(0,0,0,.01);
    margin: 18px 0;
  }

  .proj {
  display: grid;
  grid-template-columns: 0.95fr 1.05fr; /* give images more space */
  gap: 24px;
  align-items: start;
}

.imggrid2{
  display: grid;
  grid-template-columns: 1fr; /* vertical stack */
  gap: 18px;
}
  

  .proj p { margin: 0 0 12px; line-height: 1.7; }
  .proj ul { margin: 8px 0 0 18px; }
  .proj li { margin: 6px 0; }

  .tag {
    display: inline-block;
    padding: 4px 10px;
    border-radius: 999px;
    border: 1px solid rgba(0,0,0,.12);
    background: white;
    font-size: .85rem;
    margin-bottom: 10px;
  }

  .imgbox img{
    width: 100%;
    height: auto;
    display: block;
    border-radius: 12px;
    border: 1px solid rgba(0,0,0,.08);
  }

  .caption{
    margin-top: 8px;
    font-size: .92rem;
    opacity: .82;
    line-height: 1.55;
  }

  /* Project 2: two images */
  .imggrid2{
    display: grid;
    grid-template-columns: 1fr 1fr;
    gap: 12px;
  }

  .divider{
    height: 1px;
    background: rgba(0,0,0,.08);
    margin: 14px 0 0;
  }

  @media (max-width: 900px){
    .proj { grid-template-columns: 1fr; }
    .imggrid2 { grid-template-columns: 1fr; }
  }
</style>

<div class="wrap">

  <h1 class="page-title">Research</h1>
  <p class="lede">
    Our lab develops biomarker-driven strategies to enable <strong>early detection, risk stratification, and precision prevention</strong>.
    We combine mechanistic insight with clinically grounded assay development.
  </p>

  <!-- PROJECT 1 -->
  <div class="card">
    <div class="proj">
      <div>
        <span class="tag">Project 1</span>
        <h2>Precision prevention and early detection</h2>
        <p>
          We seek to identify <strong>measurable biological signals</strong> that emerge before clinically evident cancer,
          enabling non-invasive detection, longitudinal surveillance, and risk-adapted intervention.
        </p>

        <p><strong>Conceptual focus</strong></p>
        <ul>
          <li>Pre-diagnostic and early tumor–associated biological states</li>
          <li>Risk stratification beyond presence/absence of disease</li>
          <li>Prevention-oriented clinical decision support</li>
        </ul>

        <p style="margin-top:12px;"><strong>Approach</strong></p>
        <ul>
          <li>Carefully curated clinical cohorts</li>
          <li>PRoBE-style principles when feasible</li>
          <li>Emphasis on assays compatible with real-world clinical workflows</li>
        </ul>
      </div>

      <div class="imgbox">
        <img src="/assets/img/Project_1.jpg" alt="Project 1 schematic">
        <div class="caption">
          Conceptual framework linking early biological changes to biomarker detection and risk-adapted intervention.
        </div>
      </div>
    </div>
  </div>

  <!-- PROJECT 2 -->
  <div class="card">
    <div class="proj">
      <div>
        <span class="tag">Project 2</span>
        <h2>Biomarker panels and assay development</h2>
        <p>
          Our work prioritizes <strong>translation</strong>, with a focus on developing assays that are analytically robust,
          scalable, and deployable in clinical laboratories.
        </p>

        <p><strong>Translation priorities</strong></p>
        <ul>
          <li>Multiplex protein biomarker panels (primarily urine-based)</li>
          <li>Reproducible quality-control and analytical validation frameworks</li>
          <li>Systematic bridging from discovery platforms to targeted, locked assays</li>
        </ul>
      </div>

      <div class="imgbox">
<div class="imggrid2">
  <img src="/assets/img/Project_2_1.jpg" alt="Project 2 schematic: assay development">
  <img src="/assets/img/Project_2_2.jpg" alt="Project 2 schematic: analytical validation">
</div>
        <div class="caption">
          Building practical, clinically scalable biomarker assays—from discovery through validation and deployment.
        </div>
      </div>
    </div>
  </div>

  <!-- PROJECT 3 -->
  <div class="card">
    <div class="proj">
      <div>
        <span class="tag">Project 3</span>
        <h2>Spatial and multi-omics biology</h2>
        <p>
          We connect <strong>tissue-level biology</strong> to measurable biomarkers and clinical outcomes,
          enabling mechanistic interpretation of non-invasive signals.
        </p>

        <p><strong>Representative methods</strong></p>
        <ul>
          <li>Spatial transcriptomics and spatial proteomics</li>
          <li>Bulk profiling with targeted validation</li>
          <li>Integrative analysis across cohorts, platforms, and experimental models</li>
        </ul>
      </div>

      <div class="imgbox">
        <img src="/assets/img/Project_3.jpg" alt="Project 3 schematic">
        <div class="caption">
          Integrating spatial biology and multi-omics to link tissue states with liquid biomarkers and outcomes.
        </div>
      </div>
    </div>
  </div>

  <!-- PROJECT 4 -->
  <div class="card">
    <div class="proj">
      <div>
        <span class="tag">Project 4</span>
        <h2>Experimental models to support temporal biology</h2>
        <p>
          We leverage experimental models to understand <strong>how early tumor-associated states evolve over time</strong>
          and how these dynamics shape detectable biomarker signals.
        </p>

        <p><strong>Goals</strong></p>
        <ul>
          <li>Define temporal trajectories of tumor initiation and progression</li>
          <li>Link evolving tissue biology to urine- and tissue-based biomarkers</li>
          <li>Support hypothesis-driven interpretation of clinical findings</li>
        </ul>
      </div>

      <div class="imgbox">
        <img src="/assets/img/Project_4.jpg" alt="Project 4 schematic">
        <div class="caption">
          Modeling temporal evolution of early lesions to interpret biomarker emergence and progression risk.
        </div>
      </div>
    </div>
  </div>

  <div class="divider"></div>

  <p style="margin:16px 0 0; font-size:.98rem;">
    If you’d like to collaborate, please reach out via <a href="/contact">Contact</a>.
  </p>

</div>
